View PHARMExcel expands quality and regulatory capabilities

PHARMExcel expands quality and regulatory capabilities

CRO PHARMExcel today announced the launch of Dot Compliance eQMS, an innovative, cloud-based Quality and Compliance Management (QMS) solution that will enhance its business quality and clinical management operations.

Read More

View PHARMExcel recognised for investment in high performing workforce

PHARMExcel recognised for investment in high performing workforce

Our jubilant PHARMExcel team celebrates its achievement as finalist at the prestigious Investors in People Awards 2022, London, UK

Read More

View PHARMExcel wins Best Business of the Year

PHARMExcel wins Best Business of the Year

We’re proud and delighted to be announced as the winner of the SME Business of the Year Award and thank the judges for recognising PHARMExcel as an exceptional business driving innovation and outstanding service in the drug development sector.

Read More

View PHARMExcel shortlisted in the investors in people awards 2022

PHARMExcel shortlisted in the investors in people awards 2022

PHARMExcel has made the final shortlist for The Award for Small Employer of the Year in The Investors in People Awards 2022.

Read More

View PHARMExcel CEO nominated for Best Businesswoman of the Year Award

PHARMExcel CEO nominated for Best Businesswoman of the Year Award

PHARMExcel is delighted to celebrate the achievements of its Founder and CEO, Yvanne Enever, who has been nominated Businesswoman of the Year at the SME Hertfordshire Business Awards 2022.

Read More

View PHARMExcel shortlisted to win Business of the Year Award

PHARMExcel shortlisted to win Business of the Year Award

PHARMExcel is proud to be shortlisted to win Business of the Year 2022 at the SME Hertfordshire Business Awards. The award recognises innovation, commercial boldness and outstanding management practices.

Read More

View PHARMExcel are pleased to announce their latest Lancet publication on Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters

PHARMExcel are pleased to announce their latest Lancet publication on Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters

Read More

View PHARMExcel are pleased to announce the publication of the persistence of immunogenicity after seven Covid -19 vaccines given as third boosters

PHARMExcel are pleased to announce the publication of the persistence of immunogenicity after seven Covid -19 vaccines given as third boosters

Read More

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7